T Cell-Directed COVID-19 Peptide Vaccine Development Using Immunoinformatics

Time: 3:45 pm
day: Day Two

Details:

  • Describe the role of T cell immunity in COVID-19 and the current vaccine landscape
  • Discuss immunoinformatic discovery and validation of SARS-CoV-2 T cell epitopes and preclinical vaccine data
  • Outline plan for phase 1 clinical trial

Speakers: